Cargando…

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Zhao, Lina, Jiang, Liping, Liu, Yunhe, Wang, Xuebing, Song, Jinge, Sun, Yulin, Bai, Yinlei, Dong, Xiu, Sun, Liying, Wu, Jianxiong, Jiao, Yuchen, Zhao, Xiaohang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982315/ https://www.ncbi.nlm.nih.gov/pubmed/35384341 http://dx.doi.org/10.1002/ctm2.793

Ejemplares similares

Tumor‐derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients
por: Zhao, Lina, et al.
Publicado: (2023)

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
por: Tachtsidis, A., et al.
Publicado: (2016)

Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma
por: Ko, Josephine Mun-Yee, et al.
Publicado: (2020)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
por: Ryoo, Seung-Bum, et al.
Publicado: (2023)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
por: Christou, Niki, et al.
Publicado: (2019)

Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer
por: Wang, Yipeng, et al.
Publicado: (2018)

The molecular detection of circulating tumour cells.
por: Johnson, P. W., et al.
Publicado: (1995)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

The In Vitro Stability of Circulating Tumour DNA
por: Henao Diaz, Emanuela, et al.
Publicado: (2016)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma
por: Liang, Wenjin, et al.
Publicado: (2022)

Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
por: Rizzo, Francesca M., et al.
Publicado: (2019)

The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2023)

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample
por: Rothwell, Dominic G., et al.
Publicado: (2015)

Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients
por: Dong, Xiu, et al.
Publicado: (2020)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

Diagnostic technologies for circulating tumour cells and exosomes
por: Shao, Huilin, et al.
Publicado: (2016)

Circulating tumour DNA analysis in multiple myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2017)

Circulating Tumour DNA in Melanoma—Clinic Ready?
por: Tivey, Ann, et al.
Publicado: (2022)

Circulating tumour DNA — looking beyond the blood
por: Tivey, Ann, et al.
Publicado: (2022)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR
por: Wang, Juan, et al.
Publicado: (2021)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells
por: Lankiewicz, Silke, et al.
Publicado: (2008)

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
por: Chan, K C A, et al.
Publicado: (2007)

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
por: McEvoy, Ashleigh C., et al.
Publicado: (2018)

Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients
por: Zhao, Mengjing, et al.
Publicado: (2023)

Minimal residual disease and circulating tumor cells in breast cancer
por: Ignatiadis, Michail, et al.
Publicado: (2011)

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1995)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
por: Vessies, Daan C. L., et al.
Publicado: (2022)

High Fragmentation Characterizes Tumour-Derived Circulating DNA
por: Mouliere, Florent, et al.
Publicado: (2011)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015)

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5umhfalp4oiamp3vpifij61qq3